We are live on ! Find out more
JO

John Overdeck Two Sigma Investments

AUM $138B
1-Year Est. Return 41.87%
 

John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.

This Fund
S&P 500
This Quarter Est. Return
-3.07%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$46.8B
AUM Growth
+$933M
Cap. Flow
+$2.08B
Cap. Flow %
4.45%
Top 10 Hldgs %
8.13%
Holding
3,617
New
458
Increased
1,225
Reduced
1,321
Closed
452

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$255M
2
PGR icon
Progressive
PGR
+$244M
3
V icon
Visa
V
+$238M
4
LRCX icon
Lam Research
LRCX
+$201M
5
ELV icon
Elevance Health
ELV
+$190M

Sector Composition

Rank Sector Weight
1 Technology 17.88%
2 Healthcare 13.28%
3 Financials 10.32%
4 Industrials 9.79%
5 Consumer Discretionary 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARKK icon
3126
ARK Innovation ETF
ARKK
$6.59B
-10,100
Closed -$573K
EFOR
3127
Everforth Inc
EFOR
$1.34B
-9,535
Closed -$795K
ATLC icon
3128
Atlanticus Holdings
ATLC
$1.46B
-7,978
Closed -$445K
ATOS icon
3129
Atossa Therapeutics
ATOS
$25.3M
-5,989
Closed -$84.8K
ATXS
3130
DELISTED
Astria Therapeutics
ATXS
-19,428
Closed -$174K
AURA icon
3131
Aura Biosciences
AURA
$809M
-27,512
Closed -$226K
AVNS
3132
DELISTED
Avanos Medical
AVNS
-72,701
Closed -$1.16M
AZUL
3133
DELISTED
Azul
AZUL
-191,019
Closed -$319K
BASE
3134
DELISTED
Couchbase
BASE
-11,835
Closed -$185K
BBH icon
3135
VanEck Biotech ETF
BBH
$470M
-1,900
Closed -$298K
BBUS icon
3136
JPMorgan BetaBuilders US Equity ETF
BBUS
$9.12B
-114,900
Closed -$12.2M
BCTX
3137
Briacell Therapeutics
BCTX
$35.4M
-129
Closed -$11K
BE icon
3138
PUT
Bloom Energy
BE
$59.3B
-50,700
Closed -$1.13M
BF.B icon
3139
Brown-Forman Class B
BF.B
$13.1B
-31,143
Closed -$1.18M
BIO icon
3140
Bio-Rad Laboratories Class A
BIO
$10.2B
-2,050
Closed -$673K
BIRD icon
3141
Smartbird Inc
BIRD
$28.9M
-15,881
Closed -$111K
BIRK icon
3142
Birkenstock
BIRK
$5.89B
-17,124
Closed -$970K
KEEL
3143
Keel Infrastructure Corp
KEEL
$2.05B
-38,006
Closed -$56.6K
BKLC icon
3144
BNY Mellon US Large Cap Core Equity ETF
BKLC
$5.65B
-397,500
Closed -$14.8M
BL icon
3145
BlackLine
BL
$1.85B
-5,906
Closed -$359K
BLCO icon
3146
Bausch + Lomb
BLCO
$6.16B
-14,500
Closed -$262K
BLD
3147
DELISTED
TopBuild
BLD
-17,367
Closed -$5.41M
BLKB icon
3148
Blackbaud
BLKB
$2.16B
-3,076
Closed -$227K
BLNK icon
3149
Blink Charging
BLNK
$86.2M
-77,117
Closed -$107K
BMI icon
3150
Badger Meter
BMI
$3.82B
-1,017
Closed -$216K

Similar funds

John Overdeck's Q1 2025 Portfolio in Review

As of Q1 2025, John Overdeck held 3,617 positions worth $46.8B, up 2% from $45.9B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.

John Overdeck deployed $2.08B of net new capital in Q1 2025, opening 458 new positions and adding to 1,225 existing holdings. Its largest new stake was Advanced Micro Devices: 2,246,952 shares worth $231M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Eli Lilly, an estimated $255M trimmed.

  • John Overdeck's largest Q1 2025 buy was Advanced Micro Devices: 2,246,952 shares worth $231M.
  • John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $510M increase.
  • John Overdeck's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $255M.
  • John Overdeck fully exited Coinbase in Q1 2025, selling an estimated $45M.
  • John Overdeck's ten largest holdings make up 8.1% of its $46.8B portfolio in Q1 2025.
  • John Overdeck opened 458 new positions and closed 452 in Q1 2025.
  • John Overdeck's portfolio value rose 2% quarter-over-quarter to $46.8B.

Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.